申请人:Palatin Technologies, Inc.
公开号:US20210198201A1
公开(公告)日:2021-07-01
A compound of the formula
where R
1
, R
2
, R
3
, R
4
, R
5
, R
6a
, and R
6b
are as defined in the specification and claims, or an enantiomer, stereoisomer or diastereoisomer thereof, or a pharmaceutically acceptable salt thereof, and the use thereof in the treatment of diseases, disorders, syndromes and conditions responsive to modulation of a melanocortin receptor.